BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38598462)

  • 21. Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer.
    Kudo Y; Saji H; Shimada Y; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Lung Cancer; 2013 Aug; 81(2):187-93. PubMed ID: 23664031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
    Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
    Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
    Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
    Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
    Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
    Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multivariate survival analysis of patients with stage I NSCLC].
    Pei J; Han B; Zhang J; Gu A
    Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):926-32. PubMed ID: 22152692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extent of mediastinal nodal dissection in stage I non-small cell lung cancer with a radiological pure-solid appearance.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Eur J Surg Oncol; 2021 Jul; 47(7):1797-1804. PubMed ID: 33745792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.
    Shi CL; Zhang XY; Han BH; He WZ; Shen J; Chu TQ
    Med Oncol; 2011 Dec; 28(4):1441-6. PubMed ID: 20661664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of surgically resected peripheral non-small cell lung cancer with a tumor diameter of 1.0 cm or less.
    Baba T; Uramoto H; Kuwata T; Oka S; Shigematsu Y; Nagata Y; Shimokawa H; Takenoyama M; Hanagiri T; Tanaka F
    Scand J Surg; 2011; 100(3):153-8. PubMed ID: 22108741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin-section computed tomography.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Lung Cancer; 2017 Nov; 113():7-13. PubMed ID: 29110852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
    Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic ability of new T1 descriptors in the tumour, node and metastasis classification of surgically treated non-small-cell lung cancer.
    Takenaka T; Yamazaki K; Miura N; Takeo S
    Interact Cardiovasc Thorac Surg; 2018 Nov; 27(5):714-719. PubMed ID: 29788086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer.
    Iskender I; Kadioglu SZ; Cosgun T; Kapicibasi HO; Sagiroglu G; Kosar A; Kir A
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):874-9. PubMed ID: 22423060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung cancer with localized ground-glass attenuation represents early-stage adenocarcinoma in nonsmokers.
    Seki N; Sawada S; Nakata M; Inoue T; Nishimura R; Segawa Y; Shibakuki R; Eguchi K
    J Thorac Oncol; 2008 May; 3(5):483-90. PubMed ID: 18449000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.
    Ito T; Murakawa T; Sato H; Tanabe A; Maekawa M; Yoshida Y; Fukayama M; Nakajima J
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):633-8. PubMed ID: 22740516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy.
    Tsuchiya T; Akamine S; Muraoka M; Kamohara R; Tsuji K; Urabe S; Honda S; Yamasaki N
    Lung Cancer; 2007 Jun; 56(3):341-8. PubMed ID: 17350137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
    Wang J; Wu N; Lv C; Yan S; Yang Y
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer.
    Lin Y; Lin WY; Kao CH; Yen KY; Chen SW; Yeh JJ
    Anticancer Res; 2012 Nov; 32(11):5087-91. PubMed ID: 23155285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of preoperative biopsy in radiological solid-dominant clinical stage I non-small-cell lung cancer.
    Huang CS; Chien HC; Chen CK; Yeh YC; Hsu PK; Chen HS; Hsieh CC; Hsu HS; Huang BS; Shih CC
    Interact Cardiovasc Thorac Surg; 2021 Apr; 32(4):537-545. PubMed ID: 33332546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.